Publication | Closed Access

Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery

Surgical OncologyGastrointestinal OncologyRadical SurgeryMedicineJunctional CancerCancer ManagementGastroenterologyAdjuvant ChemotherapySurgeryUpper Gastrointestinal SurgeryCancer TreatmentOncologyRadiation OncologyCancer Research